Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes
Open Access
- 8 March 2017
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 8 (1) , e00117-17
Abstract
A century ago, Emil von Behring passed away. He was the first to be honored by the Nobel Prize for Medicine in 1901 for the successful therapy of diphtheria and tetanus, which he had developed from the bench to the bed. He also contributed to the foundation of immunology, since his therapy was based on passive immunization with specific antisera. Being an ambitious character, he did not shy away from friction with his colleagues Paul Ehrlich and Elias Metchnikoff and his mentor, Robert Koch. Behring was not only an excellent translational researcher but also a successful entrepreneur and early proponent of public-private partnerships.Keywords
This publication has 5 references indexed in Scilit:
- Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie MetchnikoffNature Immunology, 2008
- Gesammelte Abhandlungen1915
- Ueber ein neues Diphtherieschutzmittel1)DMW - Deutsche Medizinische Wochenschrift, 1913
- ACTIVE IMMUNITY PRODUCED BY SO CALLED BALANCED OR NEUTRAL MIXTURES OF DIPHTHERIA TOXIN AND ANTITOXINJournal of Experimental Medicine, 1909
- Die Geschichte der Diphtherie; mit besonderer Berücksichtigung der Immunitätslehre1893